• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

T cell epitope Content Comparison (EpiCC) of swine H1 influenza A virus hemagglutinin

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses. 2017 Oct 20. doi: 10.1111/irv.12513. [Epub ahead of print]
[h=1]T cell epitope Content Comparison (EpiCC) of swine H1 influenza A virus hemagglutinin.[/h] Guti?rrez AH[SUP]1[/SUP], Rapp-Gabrielson V[SUP]2[/SUP], Terry FE[SUP]3[/SUP], Loving C[SUP]4[/SUP], Moise L[SUP]1,[/SUP][SUP]3[/SUP], Martin WD[SUP]3[/SUP], De Groot AS[SUP]1,[/SUP][SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Predicting vaccine efficacy against emerging pathogen strains is a significant problem in human and animal vaccine design. T cell epitope cross-conservation may play an important role in cross-strain vaccine efficacy. While influenza A virus (IAV) hemagglutination inhibition (HI) antibody titers are widely used to predict protective efficacy of one IAV vaccine against new strains, no similar correlate of protection has been identified for T cell epitopes.
[h=4]OBJECTIVE:[/h] We developed a computational method (EpiCC) that facilitates pairwise comparison of protein sequences based on an immunological property - T cell epitope content - rather than sequence identity, and evaluated its ability to classify swine IAV strain relatedness to estimate cross-protective potential of a vaccine strain for circulating viruses.
[h=4]METHODS:[/h] T cell epitope relatedness scores were assessed for 23 IAV HA sequences representing the major H1 swine IAV phylo-clusters circulating in North American swine and HA sequences in a commercial inactivated vaccine (FluSure XP[SUP]?[/SUP] ). Scores were compared to experimental data from previous efficacy studies.
[h=4]RESULTS:[/h] Higher EpiCC scores were associated with greater protection by the vaccine against strains for 23 field IAV strain-vaccine comparisons. A threshold for EpiCC relatedness associated with full or partial protection in the absence of cross-reactive HI antibodies was identified. EpiCC scores for field strains for which FluSure protective efficacy is not yet available, were also calculated.
[h=4]CONCLUSION:[/h] EpiCC thresholds can be evaluated for predictive accuracy of protection in future efficacy studies. EpiCC may also complement HI cross-reactivity and phylogeny for selection of influenza strains in vaccine development. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] IAV ; SLA ; Computational immunology; Hemagglutinin; T cell epitope content comparison; T cell epitope prediction; swine influenza H1 viruses; vaccine efficacy

PMID: 29054116 DOI: 10.1111/irv.12513
Free full text
 
Back
Top Bottom